CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹12,689 Cr | ₹11,732 Cr | ₹11,925 Cr | ₹11,628 Cr | ₹11,717 Cr |
What is the latest Total Non-Current Assets ratio of CIPLA ?
Year | Total Non-Current Assets |
---|---|
Mar2024 | ₹12,689 Cr |
Mar2023 | ₹11,732 Cr |
Mar2022 | ₹11,925 Cr |
Mar2021 | ₹11,628 Cr |
Mar2020 | ₹11,717 Cr |
How is Total Non-Current Assets of CIPLA Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹12,689 Cr | 8.16 | |
Mar2023 | ₹11,732 Cr | -1.62 | |
Mar2022 | ₹11,925 Cr | 2.55 | |
Mar2021 | ₹11,628 Cr | -0.76 | |
Mar2020 | ₹11,717 Cr | - |
Compare Total Non-Current Assets of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹118,038.8 Cr | 0.2% | 0.6% | -3.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,012.0 Cr | 4.6% | -0.9% | 5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,188.0 Cr | 0.5% | -5.5% | 57.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,512.0 Cr | -0.4% | -1.5% | 14.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,445.1 Cr | -2.2% | -8.6% | -13.4% | Stock Analytics | |
MANKIND PHARMA | ₹90,812.7 Cr | -4.9% | -10.2% | 0.3% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 0.2% |
0.6% |
-3.3% |
SENSEX | -0.7% |
-4.5% |
-0.4% |
You may also like the below Video Courses